![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RA Keith, AM Burkman, TD Sokoloski and RH Fertel
Recent reports have suggested that cyclic guanosine 3', 5'- monophosphate (cGMP) may mediate drug-induced vascular smooth muscle relaxation. This hypothesis was examined by correlating increases in cGMP formation with vascular smooth muscle relaxation after sensitivities to nitroglycerin and nitroprusside were altered. Both nitroglycerin and nitroprusside produced a concentration-dependent increase in rat aortic cGMP levels, which preceded relaxation. A specific inhibition of nitroglycerin relaxation was accomplished by pretreating helical rat aortic strips with 5.5 X 10(-4) M nitroglycerin for 1 hr (in vitro nitroglycerin tolerance). Both nitroglycerin and nitroprusside were inhibited by pretreating tissues with 10(-5) M methylene blue for 1 hr. Whenever nitroglycerin or nitroprusside relaxation was inhibited, there was a corresponding inability to generate cGMP. Vascular tissues derived from nitroglycerin-tolerant animals (in vivo tolerance) exhibited a profile of cGMP reduction that closely resembled that of the in vitro model. Vascular smooth muscle relaxation induced by 8-bromoguanosine-3', 5'-monophosphoric acid was not inhibited by either in vitro nitroglycerin tolerance or methylene blue, suggesting that the subsequent action of cGMP, once formed, is not impaired. The results of this study support the contention that cGMP generation may be an important step in the promotion of vascular smooth muscle relaxation by nitroglycerin and nitroprusside.
This article has been cited by other articles:
|
|
 |
|
  J. C. Irvine, J. L. Favaloro, R. E. Widdop, and B. K. Kemp-Harper Nitroxyl Anion Donor, Angeli's Salt, Does Not Develop Tolerance in Rat Isolated Aortae Hypertension, April 1, 2007; 49(4): 885 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hatanaka, K. Ihara, M. Kodera, K. Katayama, and T. Koizumi Stereoselective Pharmacokinetics and Pharmacodynamics of Organic Nitrates in Rats J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 346 - 353. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. M. Hamad, S. P. Range, E. Holland, and A. J. Knox Desensitization of Guanylyl Cyclases in Cultured Human Airway Smooth-Muscle Cells Am. J. Respir. Cell Mol. Biol., May 1, 1999; 20(5): 1087 - 1095. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. M. Mohazzab-H., P. M. Kaminski, R. Agarwal, and M. S. Wolin Potential Role of a Membrane-Bound NADH Oxidoreductase in Nitric Oxide Release and Arterial Relaxation to Nitroprusside Circ. Res., February 5, 1999; 84(2): 220 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Patel and J. Diamond Activation of Guanosine 3',5'-Cyclic Monophosphate (cGMP)-Dependent Protein Kinase in Rabbit Aorta by Nitroglycerin and Sodium Nitroprusside J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 885 - 893. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
